Search

Your search keyword '"Picolinic Acids administration & dosage"' showing total 161 results

Search Constraints

Start Over You searched for: Descriptor "Picolinic Acids administration & dosage" Remove constraint Descriptor: "Picolinic Acids administration & dosage"
Sorry, I don't understand your search. ×
161 results on '"Picolinic Acids administration & dosage"'

Search Results

1. The Effectiveness and Safety of a Nutraceutical Combination in Overweight Patients with Metabolic Syndrome.

2. Chromium nanoparticles improve bone turnover regulation in rats fed a high-fat, low-fibre diet.

Catalog

Books, media, physical & digital resources

3. Efficacy of phytase and/or chromium tripicolinate supplementation on dry matter and nitrogen digestibility and blood metabolites in grower pigs.

4. Evaluating the toxicity of escalating dose of oral picolinic acid in Sprague-Dawley rats.

5. Negative allosteric modulation of metabotropic glutamate receptor 5 attenuates alcohol self-administration in baboons.

6. Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.

7. Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics.

8. Effects of dietary chromium picolinate supplementation on broiler growth performance: A meta-analysis.

9. Improvement in the growth status and carbohydrate utilization of Labeo rohita (Hamilton, 1822) fingerlings with dietary supplementation of chromium picolinate.

10. The effect of the high-fat diet supplemented with various forms of chromium on rats body composition, liver metabolism and organ histology Cr in liver metabolism and histology of selected organs.

11. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.

12. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.

13. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.

14. Long-term chromium picolinate supplementation improves colostrum profile of Santa Ines ewe.

15. Inflammation-responsive functional Ru nanoparticles combining a tumor-associated macrophage repolarization strategy with phototherapy for colorectal cancer therapy.

16. Dietary supplementation of organic or inorganic chromium modulates the immune responses of broilers vaccinated with Avian Influenza virus vaccine.

17. Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.

18. Targeted radiotherapy of pigmented melanoma with 131 I-5-IPN.

19. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.

20. Effects of chromium picolinate supplementation on growth, body composition, and biochemical parameters in Nile tilapia Oreochromis niloticus.

21. Dietary Supplementation with Chromium Picolinate Influences Serum Glucose and Immune Response of Brown-Egg Laying Hens.

22. Pharmacokinetics and bioavailability of chromium malate and its influence on trace metals absorption after oral or intravenous administration.

23. Dietary supplementation of l-arginine and chromium picolinate in sows during gestation affects the muscle fibre characteristics but not the performance of their progeny.

24. Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers.

25. Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy.

26. A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation.

27. Liposomes Containing Lipid-Soluble Zn(II)-Bis-dipicolylamine Derivatives Show Potential To Be Targeted to Phosphatidylserine on the Surface of Cancer Cells.

28. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.

29. Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor-treated APP transgenic mice.

30. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.

31. The effects of organic chromium on adipose anatomical parts, using pig as experimental model.

32. Effect of chromium picolinate and melatonin either in single or in a combination in high carbohydrate diet-fed male Wistar rats.

33. Beneficial effects of oral chromium picolinate supplementation on glycemic control in patients with type 2 diabetes: A randomized clinical study.

34. A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.

35. Effects of dietary supplementation of organic chromium (picolinate) on physical and biochemical characteristics of semen and carcass traits of male turkeys.

36. Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

37. Performance, egg quality traits, and serum metabolite concentrations of laying hens affected by dietary supplemental chromium picolinate and vitamin C under a heat-stress condition.

38. Large amounts of picolinic acid are lethal but small amounts increase the conversion of tryptophan-nicotinamide in rats.

39. Nutraceuticals for metabolic syndrome management: from laboratory to benchside.

40. Chromium picolinate supplementation for overweight or obese adults.

41. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.

42. Chromium picolinate attenuates hyperglycemia-induced oxidative stress in streptozotocin-induced diabetic rats.

43. Toxicity evaluation of chromium picolinate nanoparticles in vivo and in vitro in rat.

44. Bioavailability of chromium(III)-supplements in rats and humans.

45. Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.

46. Chromium picolinate modulates serotonergic properties and carbohydrate metabolism in a rat model of diabetes.

47. Efficacy of dietary chromium (III) supplementation on tissue chromium deposition in finishing pigs.

48. Renal distal tubule proliferation and increased aquaporin 2 level but decreased urine osmolality in db/db mouse: treatment with chromium picolinate.

49. Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on L: -DOPA-induced dyskinesia.

50. Effect of chromium picolinate supplementation on growth performance and meat characteristics of swine.